See the impact
before you
commit.
Pharmagro helps life sciences teams model uncertainty, compare scenarios, and see portfolio impact before committing capital and resources.
THE DECISIONS
Decisions that
shape the portfolio.
Where should we keep
What could our portfolio look
like under different futures?
Where should we commit
limited capacity?
BUILT FOR PORTFOLIO DECISIONS ACROSS:
CDMOs
Commercial, BD & operations teams
Pharma
R&D, portfolio & strategy teams
Biotech
Leadership & strategy teams
From uncertainty
to a decision you
can stand behind.
Pharmagro gives teams a structured way to move from uncertain assumptions to clearer portfolio decisions.
Clarify assumptions
Identify what drives uncertainty and define realistic ranges for better-informed decisions.
- Surface key drivers
- Define realistic ranges

Explore alternatives
Compare possible scenarios to see how changing assumptions could shape future outcomes.
- Compare possible futures
- Test changing assumptions

Understand implications
Quantify portfolio impact and reveal the trade-offs behind different choices.
- Quantify portfolio impact
- Reveal critical trade-offs

Decide with confidence
Choose where to commit limited resources based on the trade-offs that matter most.
- Compare decision paths
- Prioritize limited resources

Explore the
Pharmagro platform
Pharmagro helps teams make uncertainty, alternatives and trade-offs easier to see — before resources are committed.

Software when it’s enough.
Expert support when it isn’t.

Not every portfolio decision fits neatly into a model. When the context is more complex,
Pharmagro can combine the platform with hands-on portfolio expertise. Work with Pharmagro on a focused
Frame the decision
Clarify the question, assumptions and trade-offs that matter.
Build the right model
Structure complex portfolio scenarios around your specific context.
Work through the implications
Interpret results and support the team as it evaluates the decision.
Built around real
portfolio decisions.
Portfolio size managed across client engagements
Global manufacturing networks modelled and optimised
Portfolios spanning multiple therapeutic modalities
Client names shared with permission.
Thinking through
complex portfolio
decisions.
Case Study : Choosing the Right Manufacturing Partner for a Phase 3 Biologic
How we navigated compounding process changes, non-comparable proposals, and hidden CDMO risks.
Case Study: Technical Due Diligence on a Biologic
In just four weeks we provided a strong analysis of CMC elements, embedded in financial, legal and operational issues.
P2MT Software Update
We have made our Pharmagro Portfolio ManagementTool P2MT easier to use! In the Evaluation Section we have added templates. Use these to get started quickly on your evaluations.
Bring us the portfolio decision you need to make.
See how Pharmagro could help your team structure the uncertainty, explore alternative scenarios and move toward a clearer decision.